Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03980366 · ClinicalTrials.gov registry record · NA
Use of Electroconvulsive Therapy to Treat Self-Injurious Behavior in Adults With Autism Spectrum Disorders
A NA study, sponsored by Eastern Virginia Medical School.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03980366: Clinical Trial NA study, sponsored by Eastern Virginia Medical School.
NCT03980366 is a NA study that was terminated before completion, run by Eastern Virginia Medical School. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03980366, a NA study, was terminated before completion, sponsored by Eastern Virginia Medical School.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to use formal measures to monitor the outcome of using electroconvulsive therapy to treat self-injurious behavior in adults with Autism Spectrum Disorder for whom psychotropic medication has not worked. This study will be fundamentally different from the previously published literature on the subject in that this will be a prospective study which will aim to recruit multiple participants in an open label study.
Primary Outcome
Self-Injury Trauma Scale (SIT). This scale allows differentiation and quantification of self-injury completed by the physician based on a complete medical assessment, location of injury, type of injury, number of injuries, and an estimate of severity. Scales include: * Number Index (NI) - Scores range from 0 (no current injuries) to 5 (17 or more current injuries) * Severity Index (SI) - Scores range from 0 (no current injuries) to 5 (maximum severity of current injuries) * Estimate of Current
Interventions
- DEVICE Electroconvulsive Therapy (ECT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-03-15 |
| Est. Completion | 2020-09-09 |
| Phase | NA |
Why NCT03980366 stopped before completion
NCT03980366 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Electroconvulsive Therapy (ECT) is the first listed.
NCT03980366 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03980366 about?
NCT03980366 is a clinical study titled "Use of Electroconvulsive Therapy to Treat Self-Injurious Behavior in Adults With Autism Spectrum Disorders". The purpose of this study is to use formal measures to monitor the outcome of using electroconvulsive therapy to treat self-injurious behavior in adults with Autism Spectrum Disorder for whom psychotropic medication has not worked. This study will be fundamentally different from the previously publi...
What is the current status of trial NCT03980366?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2019-03-15. Estimated completion is 2020-09-09.
What interventions are being tested in trial NCT03980366?
The interventions under investigation include: Electroconvulsive Therapy (ECT) (DEVICE).
Who is sponsoring clinical trial NCT03980366?
This trial is sponsored by Eastern Virginia Medical School, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03980366's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI